Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 402,000 | 446,000 | 1,034,000 | 51,000 | 482,000 |
| Receivables | 88,000 | 109,000 | 131,000 | 1,000 | 35,000 |
| Inventories | 93,000 | 101,000 | 125,000 | N/A | 70,000 |
| Other current assets | 373,000 | 387,000 | 941,000 | 1,000 | 155,000 |
| TOTAL | $956,000 | $1,043,000 | $2,231,000 | $53,000 | $742,000 |
| Non-Current Assets | |||||
| PPE Net | 2,988,000 | 3,022,000 | 3,270,000 | N/A | 3,314,000 |
| Investments And Advances | 0 | 0 | 0 | 63,000 | 0 |
| Intangibles | 51,000 | 71,000 | 96,000 | 0 | 0 |
| Other Non-Current Assets | 387,000 | 399,000 | 374,000 | 3,000 | 56,000 |
| TOTAL | $3,426,000 | $3,492,000 | $3,740,000 | $66,000 | $3,370,000 |
| Total Assets | $4,382,000 | $4,535,000 | $5,971,000 | $119,000 | $4,112,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29,000 | 29,000 | 16,000 | N/A | 4,000 |
| Accounts payable and accrued liabilities | 96,000 | 113,000 | 92,000 | 0 | 35,000 |
| Accrued Expenses | 76,000 | 68,000 | 134,000 | 24,000 | 72,000 |
| TOTAL | $369,000 | $347,000 | $867,000 | $24,000 | $200,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,353,000 | 1,386,000 | 1,661,000 | N/A | 1,832,000 |
| Other Non-Current Liabilities | 297,000 | 299,000 | 4,593,000 | 97,000 | 1,021,000 |
| TOTAL | $1,650,000 | $1,685,000 | $6,254,000 | $97,000 | $2,853,000 |
| Total Liabilities | $2,019,000 | $2,032,000 | $7,121,000 | $121,000 | $3,053,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | -249,000 | -107,000 | -6,286,000 | -5,963,000 | -4,899,000 |
| Other shareholders' equity | 11,000 | 11,000 | -24,000 | -50,000 | -52,000 |
| TOTAL | $2,363,000 | $2,503,000 | $-1,150,000 | $-2,000 | $1,059,000 |
| Total Liabilities And Equity | $4,382,000 | $4,535,000 | $5,971,000 | $119,000 | $4,112,000 |